Related Experiment Videos
P-ANCA cranial pachymeningitis: a case report.
D Jacobi1, F Maillot, C Hommet
1Service de Medecine Interne A, CHU Bretonneau, Centre Hospitalier Universitaire, 2 bis, boulevard Tonnelle, Tours, 37000, France.
Clinical Rheumatology
|December 4, 2004
Summary
Pachymeningitis, an inflammation thickening the dura mater, can be triggered by autoimmune diseases. Early recognition and immunosuppressive therapy are crucial for preventing neurological damage, as seen in an MPO-ANCA-positive patient.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Pachymeningitis involves inflammation and thickening of the dura mater, with diverse potential causes including infections, neoplasms, and autoimmune conditions.
- The case highlights a patient presenting with symptoms suggestive of a neurological vasculitis following hepatitis B vaccination.
Observation:
- A 51-year-old woman experienced rhinitis, otitis media, headaches, and neurological decline post-hepatitis B vaccination.
- Following a booster dose, she developed unilateral vision loss and cranial nerve palsies.
- Blood tests revealed inflammation and antimyeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA), while cranial MRI confirmed pachymeningitis.
Findings:
- The patient's presentation and subsequent remission with immunosuppressive therapy strongly suggested a vasculitis affecting the nervous system.
- Although histological confirmation of vasculitis was absent, MPO-ANCA-related autoimmunity is implicated as the likely cause.
Implications:
- This case underscores the importance of considering autoimmune etiologies, particularly MPO-ANCA-associated conditions, in patients with pachymeningitis, even without prior organ involvement.
- Prompt diagnosis and initiation of immunosuppressive treatment are vital to avert irreversible neurological deficits associated with this fibrosing condition.